GSK plc
GSK
#260
Rank
โ‚ฌ83.13 B
Marketcap
41,50ย โ‚ฌ
Share price
-0.09%
Change (1 day)
11.10%
Change (1 year)

Revenue for GSK plc (GSK)

Revenue in 2026 (TTM): โ‚ฌ38.16 Billion

According to GSK plc's latest financial reports the company's current revenue (TTM ) is โ‚ฌ39.57 Billion. In 2025 the company made a revenue of โ‚ฌ37.26 Billion a decrease over the revenue in the year 2024 that were of โ‚ฌ38.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for GSK plc from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ38.16 B2.42%
2025 โ‚ฌ37.26 B-3.5%
2024 โ‚ฌ38.61 B12.62%
2023 โ‚ฌ34.28 B3.56%
2022 โ‚ฌ33.10 B-6.47%
2021 โ‚ฌ35.39 B-0.61%
2020 โ‚ฌ35.61 B-7.42%
2019 โ‚ฌ38.46 B7.99%
2018 โ‚ฌ35.62 B7.89%
2017 โ‚ฌ33.01 B-5.61%
2016 โ‚ฌ34.97 B5.78%
2015 โ‚ฌ33.06 B6.8%
2014 โ‚ฌ30.96 B2.23%
2013 โ‚ฌ30.28 B-5.24%
2012 โ‚ฌ31.96 B-4.1%
2011 โ‚ฌ33.32 B1.4%
2010 โ‚ฌ32.87 B5.24%
2009 โ‚ฌ31.23 B0.03%
2008 โ‚ฌ31.22 B0.33%
2007 โ‚ฌ31.12 B-4.24%
2006 โ‚ฌ32.50 B-0.18%
2005 โ‚ฌ32.55 B17.24%
2004 โ‚ฌ27.77 B-2.25%
2003 โ‚ฌ28.41 B-8.62%
2002 โ‚ฌ31.08 B-7.05%
2001 โ‚ฌ33.44 B15.08%
2000 โ‚ฌ29.06 B108.91%
1999 โ‚ฌ13.91 B23.28%
1998 โ‚ฌ11.28 B3.3%
1997 โ‚ฌ10.92 B-19.73%
1996 โ‚ฌ13.60 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚ฌ50.59 B 27.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ56.84 B 43.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ50.72 B 28.20%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ59.40 B 50.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ54.76 B 38.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ15.45 B-60.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
โ‚ฌ0.29 B-99.25%๐Ÿ‡บ๐Ÿ‡ธ USA